France Nuclear Imaging Market Insights Forecasts to 2033

• The France Nuclear Imaging Market Size was valued at USD 410.87 Million in 2023.
• The Market Size is Growing at a CAGR of 3.6% from 2023 to 2033
• The France Nuclear Imaging Market Size is Expected to Reach USD 585.91 Million by 2033

The France Nuclear Imaging Market Size is Anticipated to Reach USD 585.91 Million by 2033, Growing at a CAGR of 3.6% from 2023 to 2033

Market Overview

Nuclear imaging creates images by detecting radiation from various parts of the body after a radioactive tracer is administered. The images are captured on computer and film. Different types of nuclear imaging tests require different preparation procedures. The studied market growth can be attributed to a variety of factors, including an increase in the prevalence of cancer and cardiac disorders, as well as technological advances in nuclear imaging. As the elderly population is more likely to be affected by chronic diseases, the demand for monitoring, diagnosis, and treatment devices is expected to rise during the forecast period. As a result, the market under consideration will experience increased growth. Physicians from Baclesse Cancer Center in France demonstrated that an artificial intelligence (AI) program can improve image quality in half-count F-18 FDG-PET scans, paving the way for significant acquisition time reductions in standard clinical practice. Based on the findings of various studies, nuclear medicine specialists in France have begun implementing advanced technologies in PET/SPECT scans, which is expected to contribute to the growth of the market.

Report Coverage

This research report categorizes for the France nuclear imaging market based on various segments and regions and forecasts revenue growth and analyzes trends in each submarket. The report analyses the key growth drivers, opportunities, and challenges influencing the France nuclear imaging market. Recent market developments and competitive strategies such as expansion, product launch, and development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key market players and analyses their core competencies in each sub-segment of the France nuclear imaging market.

Driving Factors

The technological advancements in imaging, and hybrid systems have evolved significantly over the last decade. The major advancement in this regard is the use of combined PET modalities. PET/CT innovation has been so successful that major imaging system manufacturers no longer offer standalone PET systems. Following the success of hybrid PET/CT systems, hybrid PET/MRI and SPECT/CT systems have gained popularity. These hybrid systems can produce more precise and high-resolution images than standalone systems. They can provide both morphological and physiological information during a single examination. The growing popularity of hybrid modalities is expected to drive the France nuclear imaging market.

Restraining Factors

Factors such as ongoing reimbursement cuts for diagnostic imaging scans and rising costs of nuclear imaging systems are hampering the France nuclear imaging market.

Market Segmentation

The France nuclear imaging market share is classified into modality and application

• The SPECT segment is expected to hold the largest market share through the forecast period.

The France nuclear imaging market is segmented by moadality into SPECT and PET. Among these, the SPECT segment is expected to hold the largest market share through the forecast period. The cost-effectiveness of SPECT equipment and procedures is an important consideration. Compared to PET scanners, SPECT scanners are generally less expensive to install and operate, making them more accessible in a variety of healthcare settings. This affordability opens up SPECT technology to a broader range of healthcare facilities, including smaller clinics and hospitals with limited resources.

• The oncology segment is expected to dominate the France nuclear imaging market during the forecast period.       

Based on the application, the France nuclear imaging market is divided into cardiology, oncology, neurology, and others. Among these, the oncology segment is expected to dominate the France nuclear imaging market during the forecast period. Cancer is becoming more common around the world, and advanced nuclear imaging technology, particularly PET and SPECT, has seen significant growth due to its unparalleled ability to thoroughly examine cancer-specific molecular traits. Also, these imaging modalities aid ongoing oncology research. They contribute to the development and evaluation of new cancer treatments and therapies by providing information about the tumor's behavior, metabolism, and response to experimental drugs.

Competitive Analysis:

The report offers the appropriate analysis of the key organizations/companies involved within the France nuclear imaging market along with a comparative evaluation primarily based on their product offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.

List of Key Companies

• Canon Medical Systems Corporation
• Fujifilm Holdings Corporation
• GE Healthcare
• Koninklijke Philips NV
• Siemens Healthineers
• Curium
• Mirion technologies (capintec)
• Bracco Group
• NOVARTIS AG (ADVANCED ACCELERATOR APPLICATIONS)
• Bayer AG
• Others

Key Target Audience

• Market Players
• Investors
• End-users
• Government Authorities 
• Consulting And Research Firm
• Venture capitalists
• Value-Added Resellers (VARs)

Recent Developments

• In May 2022, Nuclear medicine doctors at the Baclesse Cancer Center in Caen, France, created an Artificial Intelligence algorithm that can be used in PET scanners to improve image quality.

Market Segment

This study forecasts revenue at France, regional, and country levels from 2020 to 2033. Spherical Insights has segmented the France nuclear imaging market based on the below-mentioned segments:

France Nuclear Imaging Market, By Modality

• SPECT
• PET

France Nuclear Imaging Market, By Application

• Cardiology
• Oncology
• Neurology
• Others